• In-depth local market knowlegde

    MORE
  • Seeking growth wherever it can be found 

    MORE
  • Undertaking responsible investment practices 

    MORE
  • Diversifing the expertise to benefit from new opportunities 

    MORE
  • Relying on experienced teams with complimentary backgrounds 

    MORE
  • Providing financial acumen and skill to our portfolio companies 

    MORE
  • Offering the best in class services to our investors 

    MORE

EXPERTISES

Since its inception in 1985, LBO France has become one of the leading Private Equity Managers in France. We have developed a multi-skilled platform focused on leveraged buyouts, venture capital, real estate and debt transactions.

  • Through the White Knight funds, LBO France invests as a majority shareholder in French champions.

    MORE
    Mid Market Buyout
  • Through the Hexagone funds, LBO France invests as the majority shareholder in dynamic French companies.

    MORE
    Small Cap Buyout
  • Innovation Capital, through SISA fund in particular, supports the growth of innovative SMEs in Digital Health and Silver Economy

    MORE
    Innovation
  • With the White Stone and Lapillus funds, LBO France has two complementary real estate strategies: opportunistic value creation and medium-term returns.

    MORE
    Real Estate
  • Through the Altercap funds, LBO France is present in the secondary debt market.

    MORE
    Debt

NEWS

  • 24
    March
    2017

    LBO France enters into exclusive negotiations with Cinven for the sale of Chryso

    LBO France announced that it has entered into exclusive negotiations for the sale of Chryso, one of the four main global specialty chemicals groups for construction materials. This sale would be the first for the fund White Knight IX.

  • 01
    March
    2017

    LBO France signs a 12-year firm lease with Groupama on its West Park building

    LBO France has signed a 12-year firm lease with Groupama for its entire West Park office building, one of the five buildings on the future 55,000 sqm campus where Groupama plans to bring together 3,200 of its employees by the end of 2017.

  • 14
    March
    2017

    Sanofi and Voluntis announce a global alliance to deliver digital insulin titration solutions for people with type 2 diabetes

    This mobile phone application is designed to help improve decision-making and self-management of type 2 diabetes for people treated with basal insulin. The application will also enable remote monitoring by health care teams. The agreement reinforces the existing alliance between the two companies, established in 2011, by expanding both its scope and geography.

  • 06
    December
    2016

    Voluntis receives FDA clearance and CE Mark for Insulia®

    The first-in-class global digital solution supports the effective management of type 2 adult diabetes patients treated with basal insulin.